In contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting toxicities and providing supportive care.
Hong Tang, MD, FACP
Hong Tang, MD, FACP, is the chief medical officer of OnQuality Pharmaceuticals, LLC.
Articles by Hong Tang, MD, FACP
Latest Updated Articles
Skin Toxicity in Cancer Treatment: A Critical Part of Cancer Supportive CarePublished: October 1st 2021 | Updated: